ASPEN PHARMACAR/ADR (OTCMKTS:APNHY) Downgraded by Zacks Investment Research
According to Zacks, “Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. “
Separately, ValuEngine upgraded ASPEN PHARMACAR/ADR from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd.
ASPEN PHARMACAR/ADR Company Profile
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. The company offers various oral solid dose, liquids, semi-solids, steriles, biogicals, active pharmaceutical ingredients, and infant nutritional products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ASPEN PHARMACAR/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASPEN PHARMACAR/ADR and related companies with MarketBeat.com's FREE daily email newsletter.